European guidelines on perinatal care: corticosteroids for women at risk of preterm birth

Detalhes bibliográficos
Autor(a) principal: Daskalakis, George
Data de Publicação: 2023
Outros Autores: Pergialiotis, Vasilios, Domellöf, Magnus, Ehrhardt, Harald, Di Renzo, Gian Carlo, Koç, Esin, Malamitsi-Puchner, Ariadne, Kacerovsky, Marian, Modi, Neena, Shennan, Andrew, Ayres-de-Campos, Diogo, Gliozheni, Elko, Rull, Kristiina, Braun, Thorsten, Beke, Artur, Kosińska-Kaczyńska, Katarzyna, Areia, Ana Luisa, Vladareanu, Simona, Sršen, Tanja Premru, Schmitz, Thomas, Jacobsson, Bo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/56304
Resumo: © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
id RCAP_522b629a5fe0dbb02ee9dd4fd6e7c3b0
oai_identifier_str oai:repositorio.ul.pt:10451/56304
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling European guidelines on perinatal care: corticosteroids for women at risk of preterm birthCorticosteroidsAntenatalGuidelinePreterm birth© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Summary of recommendations Corticosteroids should be administered to women at a gestational age between 24+0 and 33+6 weeks, when preterm birth is anticipated in the next seven days, as these have been consistently shown to reduce neonatal mortality and morbidity. (Strong-quality evidence; strong recommendation). In selected cases, extension of this period up to 34+6 weeks may be considered (Expert opinion). Optimal benefits are found in infants delivered within 7 days of corticosteroid administration. Even a single-dose administration should be given to women with imminent preterm birth, as this is likely to improve neurodevelopmental outcome (Moderate-quality evidence; conditional recommendation). Either betamethasone (12 mg administered intramuscularly twice, 24-hours apart) or dexamethasone (6 mg administered intramuscularly in four doses, 12-hours apart, or 12 mg administered intramuscularly twice, 24-hours apart), may be used (Moderate-quality evidence; Strong recommendation). Administration of two “all” doses is named a “course of corticosteroids”. Administration between 22+0 and 23+6 weeks should be considered when preterm birth is anticipated in the next seven days and active newborn life-support is indicated, taking into account parental wishes. Clear survival benefit has been observed in these cases, but the impact on short-term neurological and respiratory function, as well as long-term neurodevelopmental outcome is still unclear (Low/moderate-quality evidence; Weak recommendation). Administration between 34 + 0 and 34 + 6 weeks should only be offered to a few selected cases (Expert opinion). Administration between 35+0 and 36+6 weeks should be restricted to prospective randomized trials. Current evidence suggests that although corticosteroids reduce the incidence of transient tachypnea of the newborn, they do not affect the incidence of respiratory distress syndrome, and they increase neonatal hypoglycemia. Long-term safety data are lacking (Moderate quality evidence; Conditional recommendation). Administration in pregnancies beyond 37+0 weeks is not indicated, even for scheduled cesarean delivery, as current evidence does not suggest benefit and the long-term effects remain unknown (Low-quality evidence; Conditional recommendation). Administration should be given in twin pregnancies, with the same indication and doses as for singletons. However, existing evidence suggests that it should be reserved for pregnancies at high-risk of delivering within a 7-day interval (Low-quality evidence; Conditional recommendation). Maternal diabetes mellitus is not a contraindication to the use of antenatal corticosteroids (Moderate quality evidence; Strong recommendation). A single repeat course of corticosteroids can be considered in pregnancies at less than 34+0 weeks gestation, if the previous course was completed more than seven days earlier, and there is a renewed risk of imminent delivery (Low-quality evidence; Conditional recommendation).Taylor & FrancisRepositório da Universidade de LisboaDaskalakis, GeorgePergialiotis, VasiliosDomellöf, MagnusEhrhardt, HaraldDi Renzo, Gian CarloKoç, EsinMalamitsi-Puchner, AriadneKacerovsky, MarianModi, NeenaShennan, AndrewAyres-de-Campos, DiogoGliozheni, ElkoRull, KristiinaBraun, ThorstenBeke, ArturKosińska-Kaczyńska, KatarzynaAreia, Ana LuisaVladareanu, SimonaSršen, Tanja PremruSchmitz, ThomasJacobsson, Bo2023-02-14T14:54:19Z20232023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/56304engJ Matern Fetal Neonatal Med. 2023 Dec;36(1):21606281476-705810.1080/14767058.2022.21606281476-4954info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T17:03:47Zoai:repositorio.ul.pt:10451/56304Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:06:50.521899Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
title European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
spellingShingle European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
Daskalakis, George
Corticosteroids
Antenatal
Guideline
Preterm birth
title_short European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
title_full European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
title_fullStr European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
title_full_unstemmed European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
title_sort European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
author Daskalakis, George
author_facet Daskalakis, George
Pergialiotis, Vasilios
Domellöf, Magnus
Ehrhardt, Harald
Di Renzo, Gian Carlo
Koç, Esin
Malamitsi-Puchner, Ariadne
Kacerovsky, Marian
Modi, Neena
Shennan, Andrew
Ayres-de-Campos, Diogo
Gliozheni, Elko
Rull, Kristiina
Braun, Thorsten
Beke, Artur
Kosińska-Kaczyńska, Katarzyna
Areia, Ana Luisa
Vladareanu, Simona
Sršen, Tanja Premru
Schmitz, Thomas
Jacobsson, Bo
author_role author
author2 Pergialiotis, Vasilios
Domellöf, Magnus
Ehrhardt, Harald
Di Renzo, Gian Carlo
Koç, Esin
Malamitsi-Puchner, Ariadne
Kacerovsky, Marian
Modi, Neena
Shennan, Andrew
Ayres-de-Campos, Diogo
Gliozheni, Elko
Rull, Kristiina
Braun, Thorsten
Beke, Artur
Kosińska-Kaczyńska, Katarzyna
Areia, Ana Luisa
Vladareanu, Simona
Sršen, Tanja Premru
Schmitz, Thomas
Jacobsson, Bo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Daskalakis, George
Pergialiotis, Vasilios
Domellöf, Magnus
Ehrhardt, Harald
Di Renzo, Gian Carlo
Koç, Esin
Malamitsi-Puchner, Ariadne
Kacerovsky, Marian
Modi, Neena
Shennan, Andrew
Ayres-de-Campos, Diogo
Gliozheni, Elko
Rull, Kristiina
Braun, Thorsten
Beke, Artur
Kosińska-Kaczyńska, Katarzyna
Areia, Ana Luisa
Vladareanu, Simona
Sršen, Tanja Premru
Schmitz, Thomas
Jacobsson, Bo
dc.subject.por.fl_str_mv Corticosteroids
Antenatal
Guideline
Preterm birth
topic Corticosteroids
Antenatal
Guideline
Preterm birth
description © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
publishDate 2023
dc.date.none.fl_str_mv 2023-02-14T14:54:19Z
2023
2023-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/56304
url http://hdl.handle.net/10451/56304
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv J Matern Fetal Neonatal Med. 2023 Dec;36(1):2160628
1476-7058
10.1080/14767058.2022.2160628
1476-4954
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis
publisher.none.fl_str_mv Taylor & Francis
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134620989521920